Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Tommy Li, PhD

Director
Genmab
Edison, New Jersey, United States

Tommy Li received his PhD in Pharmaceutical Science from SUNY Buffalo. His PhD researched focused on developing mechanistic PBPK-PD model of anti-FcRn antibody. Since joining industry, he has been working in oncology/immunoncology therapeutic area. He is currently a director in the clinical pharmacology group at Genmab and worked on several bispecific programs, including Epcoritamab, as well as ADC program.

Disclosure(s): Genmab: Employment (Ongoing)

Presentation(s):

Email Tommy